Lantheus Holdings Inc (LNTH) reported disappointing financial results for the third quarter of fiscal 2025. The company posted earnings per share (EPS) of $1.27, falling short of Wall Street's expectation of $1.29. Revenue matched analyst forecasts at $0.4 billion, but the overall performance reflects challenges in meeting market expectations.
The company will host an earnings conference call at BMO to discuss these results and provide further insights into its operational performance. With a market capitalization of $3.5 billion and a trailing P/E ratio of 12.91, Lantheus continues to focus on its core areas, including radiopharmaceutical oncology and precision diagnostics.
This update provides insight into Lantheus Holdings Inc's recent financial health. Investors are encouraged to review the full earnings release and listen to management commentary for a complete context on the quarter’s performance and future outlook. Upcoming earnings are scheduled for May 4, 2026, with an EPS estimate of $1.2575 and revenue projected at $0.4 billion.